Dimitri F. Dimitriou has 25 years experience in the pharmaceutical and biotech industry. Prior to co-founding ImmuPharma, he was Senior Director, Worldwide Business Development at GlaxoSmithKline, where his responsibilities included worldwide corporate deals with pharmaceutical and biotech companies. He held a similar role in Europe for Bristol-Myers Squibb. He spent 8 years at Procter & Gamble in senior marketing, R&D and business development positions and began his career in marketing at Novartis (Sandoz) in 1987. He has a degree in biochemistry from Kings College, University of London and an MSc in pathology and toxicology from the Imperial College Medical School. Dimitri F. Dimitriou has 25 years experience in the pharmaceutical and biotech industry. Prior to co-founding ImmuPharma, he was Senior Director, Worldwide Business Development at GlaxoSmithKline, where his responsibilities included worldwide corporate deals with pharmaceutical and biotech companies. He held a similar role in Europe for Bristol-Myers Squibb. He spent 8 years at Procter & Gamble in senior marketing, R&D and business development positions and began his career in marketing at Novartis (Sandoz) in 1987. He has a degree in biochemistry from Kings College, University of London and an MSc in pathology and toxicology from the Imperial College Medical School.

Radiology, Oncology, Cancer research